Patient-Reported Outcomes of Chemotherapy Involving Non-Small Cell Lung Cancer: Evaluation by Questionnaires of Quality of Life Regarding Anti-Aging and Anti-Cancer DrugsReportar como inadecuado




Patient-Reported Outcomes of Chemotherapy Involving Non-Small Cell Lung Cancer: Evaluation by Questionnaires of Quality of Life Regarding Anti-Aging and Anti-Cancer Drugs - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Background: Patient-reported outcomes PROs of quality of life QOL during chemotherapy involving lung cancer are very important for the medical staffs. Patients’ satisfaction and healthy changes were evaluated by the patient-self assessment. Materials and Methods: From July 2007 to April 2008, a total of 19 patients received chemotherapy. The QOL data were collected by using the QOL questionnaire for cancer patients treated with anticancer drugs QOL-ACD and the anti-aging QOL assessment AA-QOL. The AA-QOL contained 51 items: 30 of physical and 21 of mental symptoms of the elderly and the aging population. The patients replied to the questions at two different times, i.e., at pre-chemotherapy baseline and at post-chemotherapy 2 weeks after the chemotherapy. Results: Regarding the hematological toxicities, for the grade 3-4 toxicities, there were 12 neutropenia 12-19, 63.2% and 3 thrombocytopenia 3-19, 15.8%. For the grade 3 febrile neutropenia, there were 5 cases 5-19, 26.3%. Regarding the non-hematological toxicities, there was no grade 3 and grade 4 toxicities. Based on the outcomes of the QOL-ACD, the three items -physical condition- -social attitude-, and -overall QOL- at post-chemotherapy became significantly worse compared to the baseline. Regarding the outcomes of the AA-QOL, 4 items of physical symptoms -thirst- -anorexia- -early satiety-, and -diarrhea- became significantly worse compared to the baseline. Regarding the mental symptoms, 2 items -nothing to look forward in life- and -a sense of uselessness- became significantly worse compared to the baseline. Conclusion: Regarding the PROs of the QOL during the chemotherapy term, both the physical and mental symptoms had become worse. To clarify the changes in the QOL during chemotherapy is very important for multidisciplinary teamwork, which should play the role of providing the appropriate cares and treatment as patient-support.

KEYWORDS

Patient-Reported Outcome, Chemotherapy, Quality of Life, Non-Small Cell Lung Cancer

Cite this paper

Ayabe, T. , Tomita, M. , Asada, T. , Tsuchiya, K. , Nemoto, M. and Nakamura, K. 2017 Patient-Reported Outcomes of Chemotherapy Involving Non-Small Cell Lung Cancer: Evaluation by Questionnaires of Quality of Life Regarding Anti-Aging and Anti-Cancer Drugs. Advances in Lung Cancer, 6, 13-35. doi: 10.4236-alc.2017.62002.





Autor: Takanori Ayabe1, Masaki Tomita1, Takashi Asada1, Kazuyo Tsuchiya1, Manabu Nemoto2, Kunihide Nakamura3

Fuente: http://www.scirp.org/



DESCARGAR PDF




Documentos relacionados